Observational studyFrontiers in immunology2026

Comparative real-world effectiveness and safety of benralizumab and two mepolizumab dosing regimens in eosinophilic granulomatosis with polyangiitis: a 24-month prospective single-center cohort study.

Marta Codirenzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.